HK1092068A1 - Dry powder composition comprising co-jet milled particles for pulmonary inhalation - Google Patents
Dry powder composition comprising co-jet milled particles for pulmonary inhalationInfo
- Publication number
- HK1092068A1 HK1092068A1 HK06113397.6A HK06113397A HK1092068A1 HK 1092068 A1 HK1092068 A1 HK 1092068A1 HK 06113397 A HK06113397 A HK 06113397A HK 1092068 A1 HK1092068 A1 HK 1092068A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- dry powder
- powder composition
- jet milled
- milled particles
- pulmonary inhalation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B02—CRUSHING, PULVERISING, OR DISINTEGRATING; PREPARATORY TREATMENT OF GRAIN FOR MILLING
- B02C—CRUSHING, PULVERISING, OR DISINTEGRATING IN GENERAL; MILLING GRAIN
- B02C19/00—Other disintegrating devices or methods
- B02C19/06—Jet mills
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0321607.4A GB0321607D0 (en) | 2003-09-15 | 2003-09-15 | Manufacture of pharmaceutical compositions |
PCT/GB2004/003996 WO2005025536A2 (en) | 2003-09-15 | 2004-09-15 | Dry powder composition comprising co-jet milled particles for pulmonary inhalation |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1092068A1 true HK1092068A1 (en) | 2007-02-02 |
Family
ID=45217849
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK06113397.6A HK1092068A1 (en) | 2003-09-15 | 2006-12-06 | Dry powder composition comprising co-jet milled particles for pulmonary inhalation |
Country Status (5)
Country | Link |
---|---|
AT (1) | ATE535233T1 (en) |
CY (1) | CY1112389T1 (en) |
ES (2) | ES2377205T3 (en) |
HK (1) | HK1092068A1 (en) |
SI (1) | SI1663155T1 (en) |
-
2004
- 2004-09-15 ES ES04768542T patent/ES2377205T3/en active Active
- 2004-09-15 SI SI200431830T patent/SI1663155T1/en unknown
- 2004-09-15 ES ES10181354.1T patent/ES2671546T3/en active Active
- 2004-09-15 AT AT04768542T patent/ATE535233T1/en active
-
2006
- 2006-12-06 HK HK06113397.6A patent/HK1092068A1/en unknown
-
2012
- 2012-02-23 CY CY20121100187T patent/CY1112389T1/en unknown
Also Published As
Publication number | Publication date |
---|---|
ATE535233T1 (en) | 2011-12-15 |
CY1112389T1 (en) | 2015-12-09 |
ES2671546T3 (en) | 2018-06-07 |
SI1663155T1 (en) | 2012-07-31 |
ES2377205T3 (en) | 2012-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL1663155T3 (en) | Dry powder composition comprising co-jet milled particles for pulmonary inhalation | |
IL179488A0 (en) | Dry powder inhaler | |
GB0525254D0 (en) | Powder compositions for inhalation | |
EP1487524A4 (en) | Dry powder inhaler | |
IL174735A (en) | Dry powder inhaler | |
GB0326632D0 (en) | Dry powder formulations | |
IL172059A0 (en) | Stabilized radiopharmaceutical compositions and methods for the preparation thereof | |
HUS1300006I1 (en) | Methods for preparing dry powder compositions of glycopyrrolate | |
EP1858521A4 (en) | Compounds and compositions as protein kinase inhbitors | |
EP1545634A4 (en) | Method of preparing dry powder inhalation compositions | |
GB0500677D0 (en) | Dry powder inhaler | |
IL175340A0 (en) | Soft steroid compositions for use in dry powder inhalers | |
ZA200408247B (en) | Dry powder inhalant composition | |
GB0416328D0 (en) | Use of dry powder compositions for pulmonary delivery | |
GB0520129D0 (en) | Pharmaceutical compositions stabilized in glassy particles | |
ZA200408245B (en) | Dry powder compositions | |
GB0321610D0 (en) | Dry powder inhaler | |
GB0219511D0 (en) | Method of preparing dry powder inhalation compositions | |
PT2474528E (en) | Antineoplasic compounds and pharmaceutical compositions thereof | |
HK1092068A1 (en) | Dry powder composition comprising co-jet milled particles for pulmonary inhalation | |
PL370285A1 (en) | Powder inhaler | |
HUP0500730A2 (en) | 1,2-diaryl-heterocyclic compounds, their preparation, pharmaceutical compositions comprising thereof and their use | |
GB0319667D0 (en) | Dry powder inhaler | |
GB0406688D0 (en) | Dry powder inhaler | |
ZA200606801B (en) | Inhalation formulations |